Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 17-year-old female patient who received BEXSERO (batch number 149001, expiry date unknown). On 7th March 2016, the patient received BEXSERO .5 ml. On 7th March 2016, less than a day after receiving BEXSERO, the patient experienced injection site pain. The patient was treated with MOTRIN. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to BEXSERO. Additional details were received as follows: This case was previously reported to a doctor. This case was reported by a certified medical assistant. The patient experienced pain at the injection site, for over 8 days. The patient had been taking over the counter MOTRIN to treat the pain. The reporter did not know the expiration date of the product. The reporter provided the 15th August 2015 as the revision date for the product.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166